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Abstract 
The chemiluminescence of stimulated cells with phorbol myristate acetate and 
the production of nitric oxide after stimulation with lipopolisaccharide in the 
presence of the parent compounds FAA (flavone-8-acetic acid = (4-oxo-2-
phenyl-4H-chromen-8-yl)acetic acid), XAA (xanthone-4-acetic acid = (9-oxo-9H-
xanthen-4-yl)acetic acid), and appropriate xanthone derivatives (1–7) was 
determined. Also the toxicity of the FAA, MFAA ((6-methyl-4-oxo-2-aryl-4H-
chromen-8-yl)acetic acid), XAA and 1–7 against J-774A.1 cultured cells was 
evaluated. Compound 5 (2-methyl-2-{[(9-oxo-9H-xanthen-2-yl)methyl]sulfanyl}-
propanoic acid) was effective in inhibiting chemiluminescence of J-774A.1 cells 
but most of the other tested compounds stimulated the reaction. FAA and two 
xanthones with a methoxycarbonyl moeity slightly decreased the generation of 
nitric oxide at 50 μM. Most of the tested compounds (1–7) showed weak toxicity 
at concentration of 100 μM. 
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Introduction 
Among the different classes of antitumor agents, the some flavone and xanthone 
derivatives are an important group of compounds with anticancer activity [1, 2]. Earlier 
studies have shown the advantageous properties of synthetic flavone-8-acetic acid (FAA, 
NSC 347512; (4-oxo-2-phenyl-4H-chromen-8-yl)acetic acid) [3] i.e. against advanced 
experimental colon tumors in mice [4]. Additionally, FAA has a different toxicity profile to 
most anticancer drugs, with no significant myelo suppression observed [5]. The related 
compounds MFAA (6-methyl-4-oxo-2-aryl-4H-chromen-8-yl)acetic acid) containing a 
6-methyl substituent in FAA showed antitumor activity comparable to FAA in vitro but were 
essentially inactive in vivo [6]. Also the closely related class of compounds FAA and 
MFAA the xanthone-4-acetic acid ((9-oxo-9H-xanthen-4-yl)acetic acid; XAA) [7] and some 
of its derivatives, in particular 5,6-dimethylxanthone-4-acetic acid ((5,6-dimethyl-9-oxo-9H-
xanthen-4-yl)acetic acid; DMXAA) [8, 9] showed promising antitumor activity. A recent 
comparative study of FAA and DMXAA, with a series of derivatives of XAA, in which the 
substituents in position 5 and 6 were included in five or six-membered rings suggest 
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Sch. 1.  
Earlier studies have shown that functions of activated macrophages such as killing of 
tumor cells, release of cytokines and generation of oxygen radicals can be regulated by 
flavone [11, 12]. They have also been shown to inhibit oxido–reductases [13], thus 
preventing the formation of free radicals resulting from the reduction of oxygen. FAA and 
analogues increases the direct cytotoxicity of murine macrophages in vitro against tumor 
targets [14], and stimulates the formation of nitric oxide [15]. Nitric oxide (NO.) is one from 
a variety of mediators released by activated macrophages. It has been identified as potent 
molecule that may exert regulatory or cytotoxic effects depending on the concentration 
acting on the target cell [16, 17]. The results of our earlier studies [18] suggest that the 
flavones can modulate the immune responses and the inflammatory reactions by 
controlling production of nitric oxide. J-774A.1 cells are functional similar to murine 
macrophages [19, 20]. 
In this study the chemiluminescence of stimulated cells with phorbol myristate acetate 
(PMA) and the production of nitric oxide after stimulation with lipopolysaccharide (LPS) in 
the presence of the parent compounds FAA, XAA and xanthone derivatives 1–7 were 
determined. 
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Results and Discussion 
Chemistry 
FAA was derived from the Drug Synthesis and Chemistry Branch, Division of Cancer 
Treatment, National Cancer Institute, USA, through the courtesy of Dr. Paull. Other 
xanthone derivatives (XAA and 1-5) were synthesized as previously described [7, 21–23]. 
Compound 6 was obtained by condensation of 2-methyl-6-hydroxyxanthone [24] with α-
bromopropionic acid according to published procedure for 4 [23]. Compound 7 was readily 
formylated according to Link [25], using 2-methyl-6-hydroxyxanthone, solid sodium 
hydroxide, acetone and chloroform. Formation of appropriate analogues of clofibrate under 
Link conditions is a widely used reaction [26,27]. Some of them (XAA, 2, 6 and 7) were 
characterized by formation of appropriate esters (XAAa, 2a, 6a and 7a) (Tab.1), according 
to well known procedures.  
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2 2-CH2-COOH 6-OMe 
2a 2-CH2-COOMe 6-OMe 
3 2-CH2-COOH 7-Cl 
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The studied compounds can influence on cell viability. Macrophages, as phagocytes 
during activation, are dynamic cells that characterize movement of cell membrane. To 
preliminary study of cytotoxic effect of tested compounds during experiments it was used 
method based on measurements of LDH leakage from the cells. Neither of the tested 
xanthone derivatives at concentration 50 µM showed toxicity against J7774A.1 cells 
cultured for 24h, but at concentration 100 µM most of them showed weak toxicity (Tab. 2). 
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Tab. 2.  Effects of tested compounds on cell viability (cytotoxic effect) determined with 
LDH method 
Cpds Cytotoxic effect at  












Percentages of cytotoxicity at concentration 
50µM of tested compounds were equal zero.  
The cells were cultured with compounds for 24h. 
The data are the mean values from three 
experiments. 
 
Stimulation of macrophages by PMA induces process, named respiratory burst, mainly 
combined with generation of reactive forms of oxygen. The process remember 
phagocytosis when the cells destroying microorganisms. The phagocytosis is important in 
defense system against invading microbial pathogens. On the other hand overproduction 
of the oxygen metabolites may induce pathologies [36–38]. 






 Nitrite concentration 
after stimulation 
with LPS [µM] 
 Mean±SEM P< Mean±SEM P< Mean±SEM P< 
Control 100  5.7±1.0  25.7±0.4  
FAA 137±8.7 0.05a 5.7±0.9 n.s. 19.2±1.4 0.05 
XAA 127±8.1 0.05 5.8±0.8 n.s 21.4±1.4 n.s. 
1 149±12.7 0.05 5.5±0.5 n.s 21.8±0.6 0.01 
2 112±4.6 n.s. 5.8±0.2 n.s 20.3±0.9 0.01 
3 114±13.3 n.s. 7.2±0.7 n.s 23.1±1.0 n.s. 
4 113±2.3 0.02 7.2±0.9 n.s 24.3±1.5 n.s. 
5 72±6.9 0.05 7.3±0.9 n.s 22.8±1.8 n.s. 
6 117±5.8 n.s. 7.2±0.5 n.s 21.9±1.3 n.s. 
7 131±4.6 0.005 5.5±0.4 n.s 22.3±1.2 n.s. 
a Level of significance of t-Student’s test. Values are compared to control (without tested 
compounds). n.s. – no significance. Concentration of tested compounds – 50µM.  
The data are the mean values from three experiments. 
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Chemiluminescence (Tab. 3) was only inhibited in the presence of compound 5 with the 
2-thio-2-methyl propionic moiety. Other of tested compounds increased or did not change 
chemiluminescence. In study [12] FAA and xanthnone acetic analogues these compounds 
changed PMA stimulated generation of superoxide anion by murine macrophages 
dependent on concentration.  
Compounds at lower concentration stimulated but at higher concentration decreased 
generation of superoxide anion. Early studies with hydroxy and methoxyxanthone 
derivatives [28] showed stimulation of protein kinase C (PKC) isoforms. PMA induces 
respiratory burst via PKC [29]. This mechanism may be in the presence of tested 
compounds. Compounds XAA and 1 (different position of the methyl carboxyl group) 
showed similar activity. Stimulation the J-774A.1 cells, as a model cells, by LPS induces 
generation of nitric oxide radical. The strong stimulation of macrophages in the body by 
pathogens generating a big amount of nitric oxygen and many other reactive substances 
destroying an environmental of the body. The activity of nitric oxide is dependent on place 
and concentration and this process is very difficult to control [39–41]. Tested compounds 
did not change generation of nitrite by unstimulated cells and slightly decreased 
generation of nitrite by stimulated J-774A.1 cells with LPS. The most activity in decreasing 
of nitrite generation was observed in the presence of FAA and xanthone derivatives with 
methyl carboxyl group. This result is in opposition to data by Thomsen [30]. That study 
was performed with FAA at higher concentration. Only 5,6-dimethyl-XAA was more active 
at low concentration. In our study concentration of tested compounds was lower because 
of cytotoxic effect. 
The tested compounds in our study have not hydroxyl substituents at the main xanthone 
structure. The hydroxyxanthone derivatives, tested by other authors, showed an inhibitory 
effect on stimulated macrophages [31, 32]. It is probably dependent on an activity of these 
groups to reaction with oxygen and nitrogen intermediates. 
The chosen most active xanthone derivatives, after additional studies, may be use as a 
modulator of process accompanying with reactions of free radicals. 
Further studies on the biological effects of the active xanthone derivatives are in progress. 
Experimental 
Chemistry  
1H NMR and 13C NMR spectra were recorded on a Bruker spectrometer 500.13 MHz, 
using signal from DMSO in DMSO-d6 and TMS in CDCl3 as internal standards. MS were 
recorded using an AMD-604 mass spectrometer (70eV). The IR spectra were recorded on 
a Perkin Elmer or Jasco FT/IR 410 spectrometer (KBr pellets). M.p.s are uncorrected and 
were determined using a Büchi SMP-20 apparatus. Microanalyses were performed in the 
Department of Pharmaceutical Chemistry of Jagiellonian University, Medical College. All 
the results were within an acceptable range. 
Mps (°C) for: XAA: 207–209 (214–215 [7], 205–207 [21]); 1: 215–217 (224–226 [7], 217–
219 [21], 215–217 [22]; 2: 236–238 [22]; 3: 222–224 [22]; 4: 182–184 [22]; 5: 205–-206 
[23]. 
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Methyl (9-oxo-9H-xanthen-4-yl)acetate (XAAa) 
Yield: 76%, m.p. 155–157°C (methanol). IR (cm-1): 2950, 1732, 1655, 1616, 1603, 1446, 
1347, 1226, 1215, 1172. 1H NMR (500.13 MHz) (δ, ppm, DMSO-d6): 8.21 (1H, dd, J = 7.9 
Hz, J = 1.7 Hz, H-8), 8.14 (1H, dd, J = 7.9 Hz, J = 1.7 Hz, H-1), 7.90 (1H, ddd, J = 8.5 Hz, 
J = 7.1 Hz, J = 1.7 Hz, H-6), 7.84 (1H, dd, J = 7.2 Hz, J = 1.7 Hz, H-3), 7.63 (1H, dd, J = 
8.5 Hz, J = 1.0 Hz, H-5), 7.51 (1H, ddd, J = 7.9 Hz, J = 7.1 Hz, J = 1.0 Hz, H-7), 7.46 (1H, 
dd, J = 7.9 Hz, J = 7.2 Hz, H-2), 4.09 (2H, s, CH2), 3.69 (3H, s, CH3). 13C NMR (500.13 
MHz) (δ, ppm, DMSO-d6): 175.92 (C=O), 170.85 (COO),155.17 (C-4b), 153.76 (C-4a), 
136.79 (C-3), 135.56 (C-6), 125.90 (C-8), 124.96 (C-1), 124.51 (C-7), 124.33 (C-4), 123.83 
(C-2), 121.02 (C-8b), 120.81 (C-8a), 118.10 (C-5), 51.86 (OCH3), 34.49 (Ar-CH2). 
C16H12O4 (268.3). 
Methyl (6-methoxy-9-oxo-9H-xanthen-2-yl)acetate (2a) 
Yield: 73%, m.p. 159–160°C (methanol). IR (cm-1): 2950, 1734, 1654, 1619, 1595, 1453, 
1256, 1162. 1H NMR (500.13 MHz) (δ, ppm, DMSO-d6): 8.09 (1H, d, J = 8.8 Hz, H-8), 8.07 
(1H, dd, J = 2.3 Hz, J = 0.5 Hz, H-1), 7.74 (1H, dd, J = 8.5 Hz, J = 2.3 Hz, H-3), 7.58 (1H, 
dd, J = 8.5 Hz, J = 0.5 Hz, H-4), 7.14 (1H, d, J = 2.4 Hz, H-5), 7.04 (1H, dd, J = 8.8 Hz, J = 
2.4 Hz, H-7), 3.93 (3H, s, CH3OAr), 3.89 (2H, s, CH2), 3.65 (3H, s, CH3). 13C NMR (500.13 
MHz) (δ, ppm, DMSO-d6): 174.73 (C=O), 171.38 (COO), 164.89 (C-6), 157.48 (C-4b), 
154.55 (C-4a), 136.21 (C-3),130.58 (C-2), 127.51 (C-8), 126.27 (C-1),120.87 (C-8b), 
117.82 (C-4),114.84 (C-8a),113.54 (C-7),100.52 (C-5), 56.07 (CH3OAr), 51.71 (OCH3), 
39.05 (CH2).C17H14O5 (298.3). 
(±)-2-[(7-Methyl-9-oxo-9H-xanthen-3-yl)oxy]propanoic acid (6) 
Yield: 63%, m.p. 201–203°C (ethanol). IR (cm-1): 3438, 2922, 1749, 1655, 1618, 1578, 
1481, 1310, 1257, 1234, 1206, 1177, 1113. 1H NMR (500.13 MHz) (δ, ppm, DMSO-d6): 
13.30 (1H, bs, CO2H), 8.10 (1H, dd, J = 8.7 Hz, J = 0.5 Hz, H-8), 7.94 (1H, ddd, J = 2.3 
Hz, J = 0.9 Hz, J = 0.5 Hz, H-1), 7.65 (1H, ddd, J = 8.5 Hz, J = 2.3 Hz, J = 0.6 Hz, H-3), 
7.53 (1H, ddd, J = 8.5 Hz, J = 0.5 Hz, J = 0.5 Hz, H-4), 7.03 (1H, dd, J = 8.7 Hz, J = 2.3 
Hz, H-7), 7.01 (1H, dd, J = 2.3 Hz, J = 0.5 Hz, H-5), 5.13 (1H, q, J = 6.8 Hz, CH), 2.43 (3H, 
ddd, J = 0.9 Hz, J = 0.6 Hz, J = 0.5 Hz, CH3Ar), 1.58 (3H, d, J = 6.8 Hz, CH3R). 13C NMR 
(500.13 MHz) (δ, ppm, DMSO-d6): 174.77 (C=O), 172.16 (COOH), 162.91 (C-6), 157.17 
(C-4b), 153.79 (C-4a), 135.98 (C-3), 133.66 (C-2), 127.64 (C-8), 125.10 (C-1), 120.78 (C-
8b),117.67 (C-4),115.19 (C-8a), 113.71 (C-7), 101.46 (C-5), 72.15 (CH-O-Ar), 20.25 (CH3-
Ar), 17.91(CH3-CH). MS (m/z): 298 (M+), 253 (100%), 226, 209, 197, 181, 169, 153, 126, 
115. C17H14O5 (298.3). 
(±)-Ethyl 2-[(7-methyl-9-oxo-9H-xanthen-3-yl)oxy]propanoate (6a) 
Yield: 71%, m.p. 121–123°C (ethanol). IR (cm-1): 2991, 2932, 1732, 1656, 1614, 1591, 
1480, 1444, 1305, 1289, 1252, 1232, 1175, 1107. 1H NMR (500.13 MHz) (δ, ppm, DMSO-
d6): 8.10 (1H, dd, J = 8.7 Hz, J = 0.5 Hz, H-8), 7.95 (1H, ddd, J = 2.3 Hz, J = 0.9 Hz, J = 
0.5 Hz, H-1), 7.66 (1H, ddd, J = 8.6 Hz, J = 2.3 Hz, J = 0.6 Hz, H-3), 7.53 (1H, dd, J = 8.6 
Hz, J = 0.5 Hz, H-4), 7.06 (1H, dd, J = 2.4 Hz, J = 0.5 Hz, H-5), 7.04 (1H, dd, J = 8.7 Hz, J 
= 2.4 Hz, H-7), 5.28 (1H, q, J = 6.8 Hz, CH), 4.19 (2H, dq, J = 10.9 Hz, J = 7.1 Hz, 
CHH(Et)), 4.17 (2H, dq, J = 10.9 Hz, J = 7.1 Hz, CHH(Et)), 2.44 (3H, dd, J = 0.9 Hz, J = 
0.6 Hz, CH3Ar), 1.59 (3H, d, J = 6.8 Hz, CH3), 1.20 (3H, t, J = 7.1 Hz, CH3(Et)). 13C NMR 
(500.13 MHz) (δ, ppm, DMSO-d6): 174.79 (C=O), 170.58 (COOH), 162.67 (C-6), 157.18 
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(C-4b), 153.81 (C-4a),136.05 (C-3), 133.71 (C-2), 127.72 (C-8), 125.12 (C-1), 120.79 (C-
8b), 117.69 (C-4),115.37 (C-8a), 113.68 (C-7), 101.70 (C-5), 72.17 (CH-O-Ar), 61.02 (CH2 
(Et)), 20.25 (CH3-Ar), 17.87 (CH3-CH),13.89 (CH3 (Et)). C19H18O5 (326.3). 
2-Methyl-2-[(7-methyl-9-oxo-9H-xanthen-3-yl)oxy]propanoic acid (7) 
Yield: 62%, m.p. 212–214°C (ethanol). IR (cm-1): 3436, 2941, 1743, 1654, 1603, 1575, 
1448, 1250, 1140, 1108.1H NMR (500.13 MHz) (δ, ppm, DMSO-d6): 13.40 (1H, s, CO2H), 
8.09 (1H, d, J = 8.9 Hz, H-8), 7.92 (1H,.d, J = 2.3 Hz, H-1), 7.61 (1H, ddd, J = 8.4 Hz, J = 
2.3 Hz, J = 0.6 Hz, H-3), 7.50 (1H, d, J = 8.5 Hz, H-4), 6.95 (1H, dd, J = 8.9 Hz, J = 2.4 Hz, 
H-7), 6.82 (1H, d, J = 2.4 Hz, H-5), 2.42 (3H, s, CH3Ar), 1.67 (6H, s, 2xCH3). 13C NMR 
(500.13 MHz) (δ, ppm, DMSO-d6): 175.99 (CO), 175.36 (COOH), 162.16 (C-6), 157.83 (C-
4b), 154.82 (C-4a), 137.11 (C-3), 134.77 (C-2), 128.60 (C-8), 126.11 (C-1), 121.73 (C-8b), 
118.75 (C-4), 116.62 (C-7), 116.18 (C-8a), 104.74 (C-5), 80.73 (C-O-Ar), 26.03 (2x CH3), 
21.34 (CH3-Ar). MS (m/z): 312 (M+), 267, 226 (100%), 197, 181, 169, 115. C18H16O5 
(312.3). 
Methyl 2-methyl-2-[(7-methyl-9-oxo-9H-xanthen-3-yl)oxy]propanoate (7a) 
Yield: 74%, m.p. 120–122°C (methanol). IR (cm-1): 2993, 2956, 1737, 1651, 1620, 1593, 
1482, 1445, 1301, 1261, 1172. 1H NMR (500.13 MHz) (δ, ppm, DMSO-d6): 8.09 (1H, d, J = 
8.9 Hz, H-8), 7.93 (1H,.d, J = 2.3 Hz, H-1), 7.63 (1H, ddd, J = 8.5 Hz, J = 2.3 Hz, J = 0.7 
Hz, H-3), 7.50 (1H, d, J = 8.5 Hz, H-4), 6.91 (1H, dd, J = 8.8 Hz, J = 2.4 Hz, H-7), 6.81 
(1H, d, J = 2.4 Hz, H-5), 3.76 (3H, s, CH3O), 2.43 (3H, s, CH3Ar), 1.68 (6H, s, 2xCH3). 13C 
NMR (500.13 MHz) (δ, ppm, DMSO-d6): 176.01 (CO), 174.10 (COOH), 161.79 (C-6), 
157.84 (C-4b), 154.86 (C-4a), 137.24 (C-3), 134.84 (C-2), 128.73 (C-8), 126.13 (C-1), 
121.73 (C-8b), 118.82 (C-4), 116.55 (C-7), 116.48 (C-8a), 105.27 (C-5), 80.75 (C-O-Ar), 
58.81 (OCH3), 26.00 (2x CH3), 21.31 (CH3-Ar). MS (m/z): 312 (M+), 267, 226 (100%), 197, 
181, 169, 115. C19H18O5 (326.3). 
Pharmacology 
Compounds were dissolved in RPMI 1640 medium without phenol red (Gibco, Grand 
Island, NY) or in Hanks buffer (HBSS) pH 7.4 without phenol red (Gibco, Grand Island, 
NY). 
J-774A.1 cells 
Murine J-774A.1 macrophages were obtained from German Collection of Microorganisms 
and Cell Cultures, Dept. Human and Animal Cell Cultures in Braunschweig. During the 
study cells were grown in RPMI 1640 medium without phenol red (Gibco, Grand Island, 
NY) supplemented with 10% fetal calf serum (FCS) (South American Origin, BIO 
WHITTAKER EUROPE, Verviers, Belgium), penicillin (100 U/mL) and streptomycin (100 
µg/mL) at 37°C and 5% CO2 atmosphere. 
During culture and experiments cell viability was controlled by lactate dehydrogenase 
method (Cytotoxicity Detection Kit (LDH)–Roche Diagnostics GmbH, Mannheim, 
Germany). 
Cell stimulation 
The adherent cells were incubated with tested compounds (0.5 h) and next stimulated with 
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lipopolisaccharide (100 ng/mL) from E.coli (0127:B8) (Calbiochem, La Jolla, CA, USA) 
After 24h culture of the cells the supernatants were removed and assayed for levels of 
nitrite.  
Nitrite assay 
Nitrite concentration in the culture medium was measured by a microplate assay method, 
based on the Griess reaction [33]. Equal volumes of culture medium supernatant and 
Griess reagent (0.5% sulfanilamide, 0.05% naphthylene-diamide dihydrochloride in 2.5% 
H3PO4) were added to microplate and incubated at 25°C for 10 min. The absorbance of 
culture medium and Griess reagent at 550nm was determined with Microplate Reader ELX 
800 (Bio-tek Instruments, Inc., Winooski, VT, USA). 
Chemiluminescence 
Into 106 cells with tested compounds or with HBSS (controls), luminol (Sigma, St. Louis, 
MO, USA) solution was added, giving a final concentration 0.1 mM and 5 min later phorbol 
myristate acetate (PMA) (Sigma, St. Louis, MO, USA) solution (final concentration 0.8 μM) 
as stimulus was used. The final volume of each sample was 1 mL. Chemiluminescence 
(CL) was measured for 20 min (5 min with luminol and 15 min, after that, PMA was added) 
using a system equipped with a photomultiplier 9514s from THORN EMI (Middlesex, 
England) [34, 35]. The intensity of CL was determined by measuring counts/min and by 
calculating the area under the CL curve. Then the percentages of control were calculated. 
Authors’ Statement 
Competing Interests 
The authors declare no conflict of interest. 
References  
[1] Lin CN, Liou SJ, Lee TH, Chuang YC, Won SJ. 
Xanthone derivatives as potential anti-cancer drugs. 
J Pharm Pharmacol. 1996; 48: 539–544. 
PMid:8799883 
[2] Kinghorn AD, Farnsworth NR, Soejarto DD, Cordell GA, Pezzuto JM, Udeani GO, Wani MC, Wall ME, 
Navarro HA, Kramer RA, Menendez AT, Fairchild CR, Lane KE, Forenza S, Vyas DM, Lam KS, 
Shu YZ. 
Novel strategies for the discovery of plant-derived anticancer agents.  
Pure Appl Chem. 1999; 71: 1611–1618. 
doi:10.1351/pac199971091611 
[3] Atassi G, Briet P, Berthelon JJ, Collonges F. 
Synthesis and antitumor activity of some 8-substituted 4-oxo-4H-1-benzopyrans.  
Eur J Med Chem. 1985; 20: 393–402. 
[4] Smith GP, Calveley SB, Smith MJ, Baguley BC. 
Flavone acetic acid (NSC 347512) induces haemorrhagic necrosis of mouse colon 26 and 38 tumours.  
Eur J Cancer Clin Oncol. 1987; 23: 1209–1211. 
doi:10.1016/0277-5379(87)90157-X 
 The Influence of some Xanthone Derivatives on the Activity of J-774A.1 Cells 751 
Sci Pharm. 2009; 77; 743–754. 
[5] Capolongo LS, Balconi G, Ubezio P, Giavazzi R, Taraboletti G, Regonesi A, Yoder OC, D'Incalci M. 
Antiproliferative properties of flavone acetic acid (NSC 347512) (LM 975), a new anticancer agent.  
Eur J Cancer Clin Oncol. 1987; 23: 1529–1535. 
doi:10.1016/0277-5379(87)90096-4 
[6] Aitken RA, Bibby MC, Double JA, Phillips RM, Sharma SK. 
Synthesis and antitumour activity of new derivatives of flavone-8-acetic acid (FAA). Part 1: 6-Methyl 
derivatives.  
Arch Pharm. 1996; 329: 489–497. 
doi:10.1002/ardp.19963291104 
[7] Rewcastle GW, Atwell GJ, Baguley BC, Calveley SB, Denny WA. 
Potential antitumor agents. 58. Synthesis and structure-activity relationships of substituted 
xanthenone-4-acetic acids active against the colon 38 tumor in vivo.  
J Med Chem. 1989; 32: 793–799. 
doi:10.1021/jm00124a012 
[8] Rewcastle GW, Atwell GJ, Li ZA, Baguley BC, Denny WA. 
Potential antitumor agents. 61. Structure-activity relationships for in vivo colon 38 activity among 
disubstituted 9-oxo-9H-xanthene-4-acetic acids.  
J Med Chem. 1991; 34: 217–222. 
doi:10.1021/jm00105a034 
[9] Zhou S, Kestell P, Baguley BC, Paxton JW. 
Preclinical factors influencing the relative contributions of phase I and II enzymes to the metabolism of 
the experimental anti-cancer drug 5,6-dimethylxanthenone-4-acetic acid.  
Biochem Pharmacol. 2003; 65: 109–120. 
doi:10.1016/S0006-2952(02)01425-9 
[10] Gobbi S, Rampa A, Bisi A, Belluti F, Valenti P, Caputo A, Zampiron A, Carrara M. 
Synthesis and antitumor activity of new derivatives of xanthen-9-one-4-acetic acid.  
J Med Chem. 2002; 45: 4931–4939. 
doi:10.1021/jm020929p 
[11] Wiltrout RH, Hornung RL. 
Natural products as antitumor agents: direct versus indirect mechanisms of activity of flavonoids.  
J Natl Cancer Inst. 1988; 80: 220–222. 
doi:10.1093/jnci/80.4.220 
[12] Thomsen LL, Baguley BC, Ching LM, Gavin JB. 
Modulation of superoxide production from murine macrophages by the antitumor agent flavone acetic 
acid and xanthenone acetic acid analogues.  
Biochem Pharmacol. 1992; 43: 386–389. 
doi:10.1016/0006-2952(92)90304-2 
[13] Hodnick WF, Kung FS, Roettger WJ, Bohmont CW, Pardini RS. 
Inhibition of mitochondrial respiration and production of toxic oxygen radicals by flavonoids. A 
structure-activity study.  
Biochem Pharmacol. 1986; 35: 2345–2357. 
doi:10.1016/0006-2952(86)90461-2 
[14] Ching LM, Baguley BC. 
Hyporesponsiveness of macrophages from C3H/HeJ (endotoxin-resistant) mice to the antitumour 
agent flavone acetic acid (NSC 347512).  
Eur J Cancer Clin Oncol. 1989; 25: 1513–1515. 
doi:10.1016/0277-5379(89)90116-8 
[15] Thomsen LL, Ching LM, Joseph WR, Baguley BC, Gavin JB. 
Nitric oxide production in endotoxin-resistant C3H/HeJ mice stimulated with flavone-8-acetic acid and 
xanthenone-4-acetic acid analogues.  
Biochem Pharmacol. 1992, 43: 2401–2406. 
doi:10.1016/0006-2952(92)90319-E 
752 H. Marona et al.:  
Sci Pharm. 2009; 77; 743–754. 
[16] Stuehr DJ, Nathan CF. 
Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target 
cells.  
J Exp Med. 1989; 169: 1543–1555. 
doi:10.1084/jem.169.5.1543 
[17] Klebanoff SJ. 
Reactive nitrogen intermediates and antimicrobial activity: role of nitrite.  
Free Radic Biol Med. 1993; 14: 351–360. 
doi:10.1016/0891-5849(93)90084-8 
[18] Król W, Czuba ZP, Threadgill MD, Cunningham BDM, Pietsz G. 
Inhibition of nitric oxide (NO.) production in murine macrophages by flavones.  
Biochem Pharmacol. 1995; 50: 1031–1035. 
doi:10.1016/0006-2952(95)00237-T 
[19] Tosk J, Lau BHS, Lui P, Myers RC, Torrey RR.  
Chemiluminescence in a macrophage cell line modulated by biological response modifiers.  
J Leukocyte Biol. 1989; 46: 103–108. 
PMid:2746137 
[20] Raso GM, Meli R, Di Carlo G, Pacilio M, Di Carlo R. 
Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in 
macrophage J774A.1.  
Life Sci. 2001; 68: 921–931. 
doi:10.1016/S0024-3205(00)00999-1 
[21] Livingstone R, editor. 
In: Coffey’s. Rodd’s Chemistry of Carbon Compounds.  
2nd ed. Volume 4, Part E.  
Amsterdam: Elsevier, 1977; 316–333. 
[22] Marona H, Eckstein M, Krupińska J, Mazur J, Piotrowicz J, Cebo B. 
Synthesis and some biological properties of 2-xanthonylalkyl-(alkoxy) carboxylic acids.  
Pol J Pharmacol Pharm. 1986; 38: 107–114. 
PMid:3489931 
[23] Marona H. 
[Synthesis of some 2-xanthonylmethylthioalkanoic acids.]  
Acta Pol Pharm. 1988; 45: 31–34  
[24] Marona H, Pękala E, Filipek B, Maciąg D, Szneler E. 
Pharmacological properties of some aminoalkanolic derivatives of xanthone. 
Pharmazie. 2001; 56: 567–572. 
PMid:11487977 
[25] Link G. 
(DRP) 80986. 
Chem Zbl. 1895; 11: 90. 
[26] von Thiele A, Jahn U, Adrian RW. 
[Beclobrate and eniclobrate hydrochloride, new diphenylmethane derivatives as agents for lowering 
cholesterol and triglyceride levels. Part I: Synthesis and consideration of structure-activity 
relationships.] 
Arzneimittelforschung. 1979; 29: 5. 
PMid:582967 
[27] Gaion RM, Valenti P, Montanari P, Da Re P. 
Xanthone analogues of clofibrate / Synthesis and biological evaluation as antagonists of lipolysis 
in vitro. 
Arzneimittelforschung. 1982; 32: 499–502. 
PMid:7201826 
 The Influence of some Xanthone Derivatives on the Activity of J-774A.1 Cells 753 
Sci Pharm. 2009; 77; 743–754. 
[28] Saraiva L, Fresco P, Pinto E, Sousa E, Pinto M, Goncalves J. 
Synthesis and in vivo modulatory activity of protein kinase C of xanthone derivatives.  
Bioorg Med Chem. 2002; 10: 3219–3227. 
doi:10.1016/S0968-0896(02)00169-4 
[29] Gescher A, Dale IL. 
Protein-kinase C – a novel target for rational anti-cancer drug design. 
Anticancer Drug Design. 1989; 4: 93–105. 
PMid:2679620 
[30] Thomsen LL, Ching LM, Baguley BC. 
Evidence for the production of nitric oxide by activated macrophages treated with the antitumor agents 
flavone-8-acetic acid and xanthenone-4-acetic acid.  
Cancer Res. 1990; 50: 6966–6970. 
PMid:/2170013 
[31] Jeong GS, Lee DS, Kim YC. 
Cudratricusxanthone A from Cudrania tricuspidata suppresses pro-inflammatory mediators through 
expression of anti-inflammatory heme oxygenase-1 in RAW264.7 macrophages. 
Int Immunopharmacol. 2009; 9: 241–246. 
doi:10.1016/j.intimp.2008.11.008 
[32] Chen LG, Yang LL, Wang CC. 
Anti-inflammatory activity of mangostins from Garcinia mangostana. 
Food Chem Toxicol. 2008; 46: 688–693. 
doi:10.1016/j.fct.2007.09.096 
[33] Green LC, Wagner DA, Glogowski J, Skipper PI, Wishnok JS, Tannenbaum SR. 
Analysis of nitrate, nitrite, and (15N) nitrate in biological fluids.  
Anal Biochem. 1982; 126: 131–138. 
doi:10.1016/0003-2697(82)90118-X 
[34] Król W, Czuba Z, Scheller S, Gabryś J, Grabiec S, Shani J. 
Anti-oxidant property of ethanolic extract of propolis (EEP) as evaluated by inhibiting the 
chemiluminescence oxidation of luminol.  
Biochem Int. 1990; 21: 593–597. 
PMid:2241984 
[35] Czuba ZP, Król W, Hasinski P, Nowowiejska A. 
The effects of taxol (paclitaxel) on chemiluminescence of neutrophils, macrophages and J.774.2 cell 
line.  
Acta Biochem Pol. 1998; 45: 103–106. 
PMid:9701502 
[36] Winterbourn CC, Kettle AJ. 
Radical-radical reactions of superoxide: a potential route to toxicity. 
Biochem Biophys Res Commun. 2003; 305; 729–736. 
doi:10.1016/S0006-291X(03)00810-6 
[37] Hultqvist M, Olsson LM, Gelderman KA, Holmdahl R. 
The protective role of ROS in autoimmune disease. 
Trends Immunol. 2009; 30: 201-208. 
doi:10.1016/j.it.2009.03.004 
[38] Greaves DR, Channon KM. 
Inflammation and immune responses in atherosclerosis. 
Trends Immunol. 2002; 23: 535–541. 
doi:10.1016/S1471-4906(02)02331-1 
754 H. Marona et al.:  
Sci Pharm. 2009; 77; 743–754. 
[39] Giang PM, Son PT, Jin HZ, Lee JH, Lee JJ. 
Comparative study on inhibitory activity of Zerumbone and Zerumbone 2,3-Epoxide on NF-κB 
activation and NO production. 
Sci Pharm. 2009; 77: 589–595. 
doi:10.3797/scipharm.0907-16 
[40] Lundberg JO, Weitzberg E, Gladwin MT. 
The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. 
Nat Rev Drug Discov. 2008; 7: 156–167. 
doi:10.1038/nrd2466 
[41] Padwad Y, Ganju L, Jain M, Chanda S, Karan D, Banerjee PK, SawhneyRC. 
Effect of extract of Seabuckthom on lipopolisaccharide induced inflammatory response in murine 
macrophages. 
Int Immunopharmacol. 2006; 6: 46–52. 
doi:10.1016/j.intimp.2005.07.015 
 
Copyright of Scientia Pharmaceutica is the property of Oesterreichische Apotheker-Verlagsgesellschaft mbH
and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright
holder's express written permission. However, users may print, download, or email articles for individual use.
